Electrocautery Ablation of High-Grade Anal Squamous Intraepithelial Lesions in HIV-Negative and HIV-Positive Men Who Have Sex With Men
- 1 March 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 59 (3), 259-265
- https://doi.org/10.1097/qai.0b013e3182437469
Abstract
Background: Anal squamous cell carcinoma (ASCC) incidence has been rising over the past decade, most dramatically in HIV-positive men who have sex with men (MSM). We aimed to identify a novel in-office approach for ablating high-grade anal intraepithelial neoplasia (HGAIN), the believed precursor lesion to ASCC. Materials and Methods We performed a retrospective analysis of medical records from a New York City surgical practice, identifying patients with HGAIN treated with electrocautery ablation (ECA) and followed for at least 5 months with high-resolution anoscopy, biopsies, and/or cytology. We sought to determine HGAIN recurrence and progression to ASCC after ECA. Results: Two hundred thirty-two MSM, 132 HIV positive and 100 HIV negative, with median follow-up of 19.0 and 17.5 months, respectively, met inclusion criterion. In HIV-negative and HIV-positive MSM, the probability of curing a lesion after first ECA was 85% and 75%, respectively. Over follow-up, 53% of HIV-negative and 61% of HIV-positive patients recurred. After first and second ECA, HIV-positive MSM were 1.28 times (P = 0.16) and 2.34 times (P = 0.009) more likely to recur than HIV-negative MSM. The majority of recurrence was due to development of additional lesions at untreated sites (metachronous recurrence). One patient (0.4%) developed ASCC. At last visit, 83% of HIV-negative and 69% of HIV-positive patients were HGAIN free. Conclusions: ECA is an effective treatment for HGAIN, with fewer patients progressing to ASCC than predicted with expectant management. HIV-positive patients are significantly more likely to recur than HIV-negative patients.Keywords
This publication has 25 references indexed in Scilit:
- The Changing Picture of High-grade Anal Intraepithelial Neoplasia in Men Who Have Sex With Men: The Effects of 10 Years of Experience Performing High-resolution AnoscopyDiseases of the Colon & Rectum, 2011
- A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimodAIDS, 2010
- Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South AfricaAIDS, 2010
- Anal cancers among HIV-infected persons: HAART is not slowing rising incidenceAIDS, 2010
- High-Resolution Anoscopy Targeted Surgical Destruction of Anal High-Grade Squamous Intraepithelial Lesions: A Ten-Year ExperienceDiseases of the Colon & Rectum, 2008
- Infrared Coagulator Ablation of High-Grade Anal Squamous Intraepithelial Lesions in HIV-Negative Males Who Have Sex with MalesDiseases of the Colon & Rectum, 2007
- MALIGNANT PROGRESSION OF ANAL INTRA‐EPITHELIAL NEOPLASIAAnz Journal of Surgery, 2006
- Infrared Coagulator™: A Useful Tool for Treating Anal Squamous Intraepithelial LesionsDiseases of the Colon & Rectum, 2005
- Treatment of grade 3 anal intraepithelial neoplasia by complete anal mucosal excision without fecal diversionDiseases of the Colon & Rectum, 1999
- Colposcopic appearance of anal squamous intraepithelial lesionsDiseases of the Colon & Rectum, 1997